We hypothesized that benign partial epilepsy in infancy (BPEI) and convulsions with
gastroenteritis (CwG) may have a similar genetic background, because previous studies
indicate that clinical features overlap between BPEI and CwG. As carbamazepine is
effective for cessation of clustering seizures in children with BPEI and CwG, some
genetic mutations regarding sodium channels may be related to the development of BPEI
and/or CwG. We focused on SCN1B encoding the voltage-dependent sodium channel β subunit. We explored SCN1B mutation in 6 children with BPEI and 6 children with CwG. Genomic DNAs were extracted
from peripheral blood samples accumulated from the patients and all 5 exons of SCN1B were amplified by standard PCR amplification. There were no SCN1B mutations or pathological single nucleotide polymorphisms in any of the patients,
although the phenotypes of our patients were typical for BPEI or CwG. Our study demonstrated
that SCN1B may not be related to the occurrence of BPEI or CwG.
Key words
benign partial epilepsy in infancy - convulsions with gastroenteritis - SCN1B - carbamazepine
- lidocaine